Emerging Therapies for IgA Nephropathy
medcases00
Published on Nov 29, 2022
Atrasentan and BION-1301 - An Interim Analyses from ERA 2022
Dr. Dana Rizk
Professor of Medicine
University of Alabama at Birmingham
Dr. Sreedhar Mandayam
Professor of Medicine
University of Texas
MD Anderson Cancer Center
Dr. Andrew King
Chief Scientific Officer
Chinook Therapeutics
www.glomcon.org
www.edu.glomcon.org
www.pubs.glomcon.org
Category
Tags
- Your Subscription
medcases00 -
Share Video
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
01:31:53KDIGO Management of Hyperkalemia: New Guidance, Emerging Evidence, and Changing Therapies
155 views 1562 days ago -
Watch Later
20:30Emerging Therapies for Managing Complement 3 Glomerulopathy
112 views 1054 days ago -
Watch Later
01:02:47The Role of the Complement System in IgA Nephropathy, C3G, & Membranous Nephropathy
119 views 1066 days ago -
Watch Later
48:32IgA Nephropathy - Fellow's Level Overview of Basic Pathophysiology and Treatment
158 views 1563 days ago -
Watch Later
01:02:15The Pathogenesis of IgA Nephropathy and Future Treatment Options. ft Dana Rizk, MD
89 views 1098 days ago -
Watch Later
58:12"Updates in IgA Nephropathy" presented by Natalie Beck, MD
153 views 1080 days ago -
Watch Later
01:08:16Updates in LN: New Era of Therapies with Dr. Alfred Kim
135 views 1312 days ago